Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 1600

BillFederalHouseIn Committee
Patients' Access to Treatments Act of 2015
About This Bill
Committee
Latest Action · March 27, 2015
Referred to the Subcommittee on Health.
Congress
114th (2015–2017)
Introduced
March 25, 2015
Cosponsors (106)
89D 17R
View PDF ↗

Summary

Highlight any text to annotate
Patients' Access to Treatments Act of 2015 Amends the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure. Prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier. Applies the non-preferred brand drug tier for which beneficiary cost-sharing is lowest, if a formulary used by the health plan contains more than one non-preferred brand drug tier.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.